1	Long-term	Long-term	B-NP	JJ	O	4	NMOD
2	Helicobacter	Helicobacter	I-NP	NN	O	4	NMOD
3	pylori	pylori	I-NP	NN	O	4	NMOD
4	infection	infection	I-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	development	development	I-NP	NN	O	13	NMOD
8	of	of	B-PP	IN	O	7	NMOD
9	atrophic	atrophic	B-NP	JJ	O	10	NMOD
10	gastritis	gastritis	I-NP	NN	O	8	PMOD
11	and	and	O	CC	O	13	NMOD
12	gastric	gastric	B-NP	JJ	O	13	NMOD
13	cancer	cancer	I-NP	NN	O	0	ROOT
14	in	in	B-PP	IN	O	13	NMOD
15	Japan	Japan	B-NP	NNP	O	14	PMOD
16	.	.	O	.	O	13	P

1	The	The	B-NP	DT	O	2	NMOD
2	incidence	incidence	I-NP	NN	O	8	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	gastric	gastric	B-NP	JJ	O	5	NMOD
5	cancer	cancer	I-NP	NN	O	3	PMOD
6	and	and	O	CC	O	8	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	prevalence	prevalence	I-NP	NN	O	12	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	Helicobacter	Helicobacter	B-NP	NN	O	11	NMOD
11	pylori	pylorus	I-NP	NNS	O	9	PMOD
12	are	be	B-VP	VBP	O	34	VMOD
13	high	high	B-ADJP	JJ	O	12	PRD
14	in	in	B-PP	IN	O	13	AMOD
15	Japan	Japan	B-NP	NNP	O	14	PMOD
16	,	,	O	,	O	12	P
17	so	so	B-SBAR	IN	O	34	VMOD
18	it	it	B-NP	PRP	O	19	SUB
19	is	be	B-VP	VBZ	O	17	SBAR
20	an	an	B-NP	DT	O	22	NMOD
21	important	important	I-NP	JJ	O	22	NMOD
22	issue	issue	I-NP	NN	O	19	PRD
23	whether	whether	B-SBAR	IN	O	22	NMOD
24	long-term	long-term	B-NP	JJ	O	27	NMOD
25	H.	H.	I-NP	NN	O	27	NMOD
26	pylori	pylori	I-NP	NN	O	27	NMOD
27	infection	infection	I-NP	NN	O	28	SUB
28	leads	lead	B-VP	VBZ	O	23	SBAR
29	to	to	B-PP	TO	O	28	VMOD
30	chronic	chronic	B-NP	JJ	O	31	AMOD
31	atrophic	atrophic	I-NP	JJ	O	32	NMOD
32	gastritis	gastritis	I-NP	NN	O	29	PMOD
33	,	,	O	,	O	34	P
34	considered	consider	B-VP	VBD	O	0	ROOT
35	one	one	B-NP	CD	O	34	OBJ
36	of	of	B-PP	IN	O	35	NMOD
37	the	the	B-NP	DT	O	38	NMOD
38	precursors	precursor	I-NP	NNS	O	36	PMOD
39	of	of	B-PP	IN	O	38	NMOD
40	gastric	gastric	B-NP	JJ	O	41	NMOD
41	cancer	cancer	I-NP	NN	O	39	PMOD
42	.	.	O	.	O	34	P

1	We	We	B-NP	PRP	O	2	SUB
2	have	have	B-VP	VBP	O	0	ROOT
3	reported	report	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	grade	grade	I-NP	NN	O	9	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	atrophy	atrophy	B-NP	NN	O	7	PMOD
9	was	be	B-VP	VBD	O	4	SBAR
10	higher	high	B-ADJP	JJR	O	9	PRD
11	in	in	B-PP	IN	O	10	AMOD
12	H.	H.	B-NP	NN	O	14	NMOD
13	pylori-positive	pylori-positive	I-NP	JJ	O	14	NMOD
14	subjects	subject	I-NP	NNS	O	11	PMOD
15	than	than	B-PP	IN	O	10	AMOD
16	in	in	B-PP	IN	O	15	PMOD
17	H.	H.	B-NP	NN	O	19	NMOD
18	pylori-negative	pylori-negative	I-NP	JJ	O	19	NMOD
19	subjects	subject	I-NP	NNS	O	16	PMOD
20	.	.	O	.	O	2	P

1	It	It	B-NP	PRP	O	2	SUB
2	has	have	B-VP	VBZ	O	0	ROOT
3	also	also	I-VP	RB	O	2	VMOD
4	been	be	I-VP	VBN	O	2	VC
5	reported	report	I-VP	VBN	O	4	VC
6	that	that	B-SBAR	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	atrophy	atrophy	I-NP	NN	O	12	SUB
9	of	of	B-PP	IN	O	8	NMOD
10	gastric	gastric	B-NP	JJ	O	11	NMOD
11	mucosa	mucosa	I-NP	NN	O	9	PMOD
12	increased	increase	B-VP	VBD	O	6	SBAR
13	in	in	B-PP	IN	O	12	VMOD
14	H.	H.	B-NP	NN	O	16	NMOD
15	pylori-infected	pylori-infected	I-NP	JJ	O	16	NMOD
16	monkeys	monkey	I-NP	NNS	O	13	PMOD
17	compared	compare	B-PP	VBN	O	12	VMOD
18	with	with	B-PP	IN	O	17	PMOD
19	control	control	B-NP	NN	O	20	NMOD
20	monkeys	monkey	I-NP	NNS	O	18	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	a	a	B-NP	DT	O	25	NMOD
23	5-year	5-year	I-NP	JJ	O	25	NMOD
24	follow-up	follow-up	I-NP	JJ	O	25	NMOD
25	study	study	I-NP	NN	O	21	PMOD
26	.	.	O	.	O	2	P

1	Most	Most	B-NP	JJS	O	4	NMOD
2	H.	H.	I-NP	NN	O	4	NMOD
3	pylori	pylori	I-NP	NN	O	4	NMOD
4	infections	infection	I-NP	NNS	O	5	SUB
5	occur	occur	B-VP	VBP	O	0	ROOT
6	in	in	B-PP	IN	O	5	VMOD
7	children	child	B-NP	NNS	O	6	PMOD
8	,	,	O	,	O	5	VMOD
9	and	and	O	CC	O	10	NMOD
10	atrophy	atrophy	B-NP	NN	O	8	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	gastric	gastric	I-NP	JJ	O	15	NMOD
14	mucosa	mucosa	I-NP	NN	O	15	NMOD
15	progresses	progress	I-NP	NNS	O	11	PMOD
16	during	during	B-PP	IN	O	10	NMOD
17	aging	aging	B-NP	NN	O	16	PMOD
18	.	.	O	.	O	5	P

1	Long-term	Long-term	B-NP	JJ	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	show	show	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	H.	H.	B-NP	NN	O	7	NMOD
6	pylori	pylori	I-NP	NN	O	7	NMOD
7	infection	infection	I-NP	NN	O	8	SUB
8	can	can	B-VP	MD	O	4	SBAR
9	lead	lead	I-VP	VB	O	8	VC
10	to	to	B-PP	TO	O	9	VMOD
11	gastric	gastric	B-NP	JJ	O	12	NMOD
12	atrophy	atrophy	I-NP	NN	O	10	PMOD
13	and	and	O	CC	O	8	VMOD
14	may	may	B-VP	MD	O	8	VMOD
15	play	play	I-VP	VB	O	14	VC
16	an	an	B-NP	DT	O	18	NMOD
17	important	important	I-NP	JJ	O	18	NMOD
18	role	role	I-NP	NN	O	15	OBJ
19	in	in	B-PP	IN	O	15	VMOD
20	the	the	B-NP	DT	O	21	NMOD
21	development	development	I-NP	NN	O	19	PMOD
22	of	of	B-PP	IN	O	21	NMOD
23	gastric	gastric	B-NP	JJ	O	24	NMOD
24	cancer	cancer	I-NP	NN	O	22	PMOD
25	.	.	O	.	O	3	P

1	Interestingly	Interestingly	B-ADVP	RB	O	4	VMOD
2	,	,	O	,	O	4	P
3	there	there	B-NP	EX	O	4	SUB
4	was	be	B-VP	VBD	O	36	VMOD
5	no	no	B-NP	DT	O	6	NMOD
6	difference	difference	I-NP	NN	O	4	PRD
7	in	in	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	prevalence	prevalence	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	H.	H.	B-NP	NN	O	12	NMOD
12	pylori	pylori	I-NP	NN	O	10	PMOD
13	between	between	B-PP	IN	O	12	NMOD
14	patients	patient	B-NP	NNS	O	20	NMOD
15	with	with	B-PP	IN	O	14	NMOD
16	chronic	chronic	B-NP	JJ	O	17	NMOD
17	gastritis	gastritis	I-NP	NN	O	15	PMOD
18	and	and	O	CC	O	20	NMOD
19	gastric	gastric	B-NP	JJ	O	20	NMOD
20	cancer	cancer	I-NP	NN	O	13	PMOD
21	in	in	B-PP	IN	O	20	NMOD
22	Japan	Japan	B-NP	NNP	O	21	PMOD
23	,	,	O	,	O	36	P
24	but	but	O	CC	O	36	VMOD
25	the	the	B-NP	DT	O	26	NMOD
26	prevalence	prevalence	I-NP	NN	O	36	SUB
27	of	of	B-PP	IN	O	26	NMOD
28	H.	H.	B-NP	NN	O	29	NMOD
29	pylori	pylori	I-NP	NN	O	27	PMOD
30	in	in	B-PP	IN	O	26	NMOD
31	young	young	B-NP	JJ	O	35	NMOD
32	Japanese	Japanese	I-NP	JJ	O	35	NMOD
33	gastric	gastric	I-NP	JJ	O	35	NMOD
34	cancer	cancer	I-NP	NN	O	35	NMOD
35	patients	patient	I-NP	NNS	O	30	PMOD
36	was	be	B-VP	VBD	O	0	ROOT
37	significantly	significantly	B-ADJP	RB	O	38	AMOD
38	higher	high	I-ADJP	JJR	O	36	PRD
39	than	than	B-PP	IN	O	38	AMOD
40	in	in	B-PP	IN	O	39	PMOD
41	the	the	B-NP	DT	O	43	NMOD
42	control	control	I-NP	NN	O	43	NMOD
43	group	group	I-NP	NN	O	40	PMOD
44	.	.	O	.	O	36	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	4	SUB
3	clearly	clearly	B-VP	RB	O	4	VMOD
4	show	show	I-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	4	VMOD
6	H.	H.	B-NP	NN	O	8	NMOD
7	pylori	pylori	I-NP	NN	O	8	NMOD
8	infection	infection	I-NP	NN	O	9	SUB
9	is	be	B-VP	VBZ	O	5	SBAR
10	one	one	B-NP	CD	O	9	PRD
11	of	of	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	14	NMOD
13	risk	risk	I-NP	NN	O	14	NMOD
14	factors	factor	I-NP	NNS	O	11	PMOD
15	of	of	B-PP	IN	O	14	NMOD
16	gastric	gastric	B-NP	JJ	O	17	NMOD
17	cancer	cancer	I-NP	NN	O	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	young	young	B-NP	JJ	O	21	NMOD
20	Japanese	Japanese	I-NP	JJ	O	21	NMOD
21	people	people	I-NP	NNS	O	18	PMOD
22	,	,	O	,	O	4	P
23	There	There	B-NP	EX	O	24	SUB
24	is	be	B-VP	VBZ	O	4	VMOD
25	no	no	B-NP	DT	O	26	NMOD
26	answer	answer	I-NP	NN	O	24	PRD
27	to	to	B-PP	TO	O	26	NMOD
28	whether	whether	B-SBAR	IN	O	27	PMOD
29	curing	cure	B-VP	VBG	O	33	SUB
30	H.	H.	B-NP	NN	O	32	NMOD
31	pylori	pylori	I-NP	NN	O	32	NMOD
32	infection	infection	I-NP	NN	O	29	OBJ
33	can	can	B-VP	MD	O	28	SBAR
34	reverse	reverse	I-VP	VB	O	33	VC
35	the	the	B-NP	DT	O	36	NMOD
36	atrophy	atrophy	I-NP	NN	O	34	OBJ
37	of	of	B-PP	IN	O	36	NMOD
38	the	the	B-NP	DT	O	40	NMOD
39	gastric	gastric	I-NP	JJ	O	40	NMOD
40	mucosa	mucosa	I-NP	NN	O	37	PMOD
41	and	and	O	CC	O	34	VMOD
42	decrease	decrease	B-VP	VB	O	34	VMOD
43	the	the	B-NP	DT	O	44	NMOD
44	risk	risk	I-NP	NN	O	42	OBJ
45	of	of	B-PP	IN	O	44	NMOD
46	gastric	gastric	B-NP	JJ	O	48	NMOD
47	cancer	cancer	I-NP	NN	O	48	NMOD
48	development	development	I-NP	NN	O	45	PMOD
49	.	.	O	.	O	4	P

1	To	To	B-VP	TO	O	2	VMOD
2	clarify	clarify	I-VP	VB	O	9	VMOD
3	this	this	B-NP	DT	O	4	NMOD
4	issue	issue	I-NP	NN	O	2	OBJ
5	,	,	O	,	O	9	P
6	an	an	B-NP	DT	O	8	NMOD
7	intervention	intervention	I-NP	NN	O	8	NMOD
8	study	study	I-NP	NN	O	9	SUB
9	must	must	B-VP	MD	O	0	ROOT
10	be	be	I-VP	VB	O	9	VC
11	done	do	I-VP	VBN	O	10	VC
12	.	.	O	.	O	9	P

1	A	A	B-NP	DT	O	4	NMOD
2	large	large	I-NP	JJ	O	4	NMOD
3	clinical	clinical	I-NP	JJ	O	4	NMOD
4	trial	trial	I-NP	NN	O	5	SUB
5	called	call	B-VP	VBD	O	0	ROOT
6	the	the	B-NP	DT	O	9	NMOD
7	Japanese	Japanese	I-NP	JJ	O	9	NMOD
8	Intervention	Intervention	I-NP	NN	O	9	NMOD
9	Trial	Trial	I-NP	NN	O	13	SUB
10	of	of	B-PP	IN	O	9	NMOD
11	H.	H.	B-NP	NN	O	12	NMOD
12	pylori	pylori	I-NP	NN	O	10	PMOD
13	is	be	B-VP	VBZ	O	5	VMOD
14	in	in	B-PP	IN	O	13	PRD
15	progress	progress	B-NP	NN	O	14	PMOD
16	.	.	O	.	O	5	P

